Panikkanvalappil Sajanlal R, Hooshmand Nasrin, El-Sayed Mostafa A
Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology , Atlanta, Georgia 30332, United States.
Bioconjug Chem. 2017 Sep 20;28(9):2452-2460. doi: 10.1021/acs.bioconjchem.7b00427. Epub 2017 Sep 7.
Despite the important applications of near-infrared (NIR) absorbing nanomaterials in plasmonic photothermal therapy (PPT), their high yield synthesis and nonspecific heating during the active- and passive-targeted cancer therapeutic strategies remain challenging. In the present work, we systematically demonstrate that in situ aggregation of typical non-NIR absorbing plasmonic nanoparticles at the nuclear region of the cells could translate them into an effective NIR photoabsorber in plasmonic photothermal therapy of cancer due to a significant shift of the plasmonic absorption band to the NIR region. We evaluated the potential of nuclear-targeted AuNSs as photoabsorber at various stages of endocytosis by virtue of their inherent in situ assembling capabilities at the nuclear region of the cells, which has been considered as one of the most thermolabile structures within the cells, to selectively destruct cancer cells with minimal damage to healthy cells. Various plasmonic nanoparticles such as rods and cubes have been exploited to elucidate the role of plasmonic field coupling in assembled nanoparticles and their subsequent killing efficiency. The NIR absorbing capabilities of aggregated AuNSs have been further demonstrated both experimentally and theoretically using discrete dipolar approximation (DDA) techniques, which was in concordance with the observed results in plasmonic photothermal therapeutic studies. While the current work was able to demonstrate the utility of non-NIR absorbing plasmonic nanoparticles as a potential alternative for plasmonic photothermal therapy by inducing localized plasmonic heating at the nuclear region of the cells, these findings could potentially open up new possibilities in developing more efficient nanoparticles for efficient cancer treatment modalities.
尽管近红外(NIR)吸收纳米材料在等离子体光热疗法(PPT)中有重要应用,但在主动和被动靶向癌症治疗策略中,其高产率合成以及非特异性加热仍然具有挑战性。在本工作中,我们系统地证明,典型的非NIR吸收等离子体纳米颗粒在细胞的核区域原位聚集,可使其在癌症的等离子体光热疗法中转化为有效的NIR光吸收剂,这是由于等离子体吸收带显著向NIR区域移动。我们凭借核靶向金纳米棒(AuNSs)在细胞的核区域固有的原位组装能力,评估了其在不同内吞阶段作为光吸收剂的潜力,细胞的核区域被认为是细胞内最不耐热的结构之一,利用这种能力可选择性地破坏癌细胞,同时对健康细胞的损伤最小。已利用各种等离子体纳米颗粒,如棒状和立方状颗粒,来阐明组装纳米颗粒中等离子体场耦合的作用及其随后的杀伤效率。聚集的AuNSs的NIR吸收能力已通过离散偶极近似(DDA)技术在实验和理论上得到进一步证明,这与等离子体光热治疗研究中的观察结果一致。虽然目前的工作能够证明非NIR吸收等离子体纳米颗粒通过在细胞的核区域诱导局部等离子体加热作为等离子体光热疗法潜在替代方案的效用,但这些发现可能为开发更高效的纳米颗粒用于有效的癌症治疗方式开辟新的可能性。